EJNMMI Research

Article	Citations
18 F-Choline-PET/CT for non-FDG-avid salivary gland cancer: a preliminary report	55
Early prediction of treatment outcome for lenvatinib using 18F-FDG PET/CT in patients with unresectable or advanced thyroid carcinoma refractory to radioiodine treatment: a prospective, multicentre, n	44
Predicting overall survival in pancreatic ductal adenocarcinoma using 18F-FDG PET/CT radiomics: a two-center study​	39
Imaging tumor and ascites-associated macrophages in a mouse model of metastatic ovarian cancer	35
18F-FAPI PET/CT imaging in pneumoconiosis: a pilot study on a novel tool for early diagnosis and guiding the treatment of pulmonary fibrosis	34
Cardiometabolic disorders affect myocardial [18F]fluorodeoxyglucose uptake– impact on diagnostic PET/CT imaging	33
Biodistribution and dosimetry of the PET radioligand [18F]CHDI-650 in mice for detection of mutant huntingtin aggregates	32
18F-FDG PET/CT-based deep learning radiomics predicts 5-years disease-free survival after failure to achieve pathologic complete response to neoadjuvant chemotherapy in breast cancer	31
Influence of corticosteroid treatment on CXCR4 expression in DLBCL	30
89Zr-mAb uptake interpretation requires the use of tissue to plasma ratios corrected for antibody catabolism	24
Change in brain amyloid load and cognition in patients with amnestic mild cognitive impairment: a 3-year follow-up study	24
[18F]F-FES PET for diagnosis, staging, and endocrine therapy prediction in ER-positive breast cancer: a systematic review and meta-analysis	24
Adenosine-induced splenic switch-off on [15O]H2O PET perfusion for the assessment of vascular vasodilatation	21
Hypometabolism and atrophy patterns associated with Niemann-Pick type C	21
Combatting the effect of image reconstruction settings on lymphoma [18F]FDG PET metabolic tumor volume assessment using various segmentation methods	21
Establishment and validation of a clinical threshold criteria for choosing PET imaging tracers for indolent non-Hodgkin’s lymphoma	20
Test-retest repeatability of quantitative organ and tissue uptake using 20-minute dynamic multiparametric whole-body [18F]FDG PET/CT in patients with type 2 diabetes	20
Preliminary mechanistic insights of a brain-penetrant microtubule imaging PET ligand in a tau-knockout mouse model	19
Predicting the effect of different folate doses on [68Ga]Ga-PSMA-11 organ and tumor uptake using physiologically based pharmacokinetic modeling	18
Radiation dosimetry and fasting-dependent hepatobiliary clearance of the VAChT-specific PET radioligand 18F-VAT in humans	18
The value of radiomics based on 2-[18 F]FDG PET/CT in predicting WHO/ISUP grade of clear cell renal cell carcinoma	17
Impact of administered amount of peptide on tumor dosimetry at the first cycle of peptide receptor radionuclide therapy (PRRT) in relation to total tumor somatostatin receptor expression	17
First clinical experience with fractionated intracavitary radioimmunotherapy using [177Lu]Lu-6A10-Fab fragments in patients with glioblastoma: a pilot study	17
Drug characteristics derived from kinetic modeling: combined 11C-UCB-J human PET imaging with levetiracetam and brivaracetam occupancy of SV2A	16
Relationship between absorbed dose and SUV derived from SPECT/CT imaging and dose-response in patients with neuroendocrine tumors treated with [¹⁷⁷Lu]Lu-DOTA-TATE	16

Quantitative renal [99mTc]DMSA imaging predicts urinary [99mTc]DMSA excretion in patients with chronic kidney disease	16
Beyond bisphosphonates: radiolabeled phosphopeptides for bone targeting	16
Correction: Combined antitumor activity of [177Lu]Lu-FAPI-2286 and pazopanib in a sarcoma model: a preclinical theranostic study targeting fibroblast activation protein	16
Integrated 68Ga-PSMA PET/MRI models improve prostate cancer diagnosis and ISUP stratification, especially in the low-PSA cohort	15
All that glitters is not gold: high uptake on PSMA PET in non-prostate cancers does not mean that treatment with [177Lu]Lu-PSMA-radioligand will be successful	15
Association of white matter injury and neuroinflammation in the post-acute phase after ischemic stroke using [18F]FEPPA-PET/MRI	15
Local staging of de novo prostate cancer using mpMRI, PSMA-PET and PSMA-PET/mpMRI – a comparative study	14
Quantification of [99mTc]Tc-HDP bone SPECT/CT: can we improve the body weight based standardized uptake value with a more robust normalization?	14
Correction: Differentiation and correlation of regional uptake heterogeneity with cardiac dysfunction in biopsy-proven transthyretin amyloid cardiomyopathy using quantitative single-photon emission co	14
PET imaging of GABAA receptors in pancreatic islets by [11C]flumazenil	13
Engineering a modular 44Ti/44Sc generator: eluate evaluation in preclinical models and estimation of human radiation dosimetry	13
CYP3A4 inhibitors do not influence [68Ga]Ga-DOTA-TATE uptake in liver tissue	13
Dosimetry and preclinical evaluation of long-term radiotoxicity following treatment with 212Pb alpha-radioimmunotherapy targeting CD20	13
Toward in vivo proof of binding of 18F-labeled inhibitor [18F]TRACK to peripheral tropomyosin receptor kinases	13
Matched-pair analysis of mCRPC patients receiving 177Lu-labeled PSMA-targeted radioligand therapy in a 4-week versus 6-week treatment interval	13
A biorthogonal chemistry approach for high-contrast antibody imaging of lymphoma at early time points	13
Hepatobiliary PET with [68Ga]Ga-BP-IDA – preclinical evaluation and its translational potential for liver function monitoring	13
Reduced splenic uptake of [68Ga]Ga-Pentixafor following first-line chemotherapy is associated with poor prognosis in patients with newly diagnosed multiple myeloma	13
Autoradiographic comparison between [11C]PiB and [18F]AZD4694 in human brain tissue	13
[18F]Fluorocholine PET/CT in a 15-year-old patient suggested HPT-JT syndrome with active cemento-ossifying fibroma	12
TCP post-radioembolization and TCP post-EBRT in HCC are similar and can be predicted using the in vitro radiosensitivity	12
Molecular imaging in hypertrophic cardiomyopathy: an exploratory study with 2-[18F]FDG and [13N]NH3	12
First-in-human use of 11C-CPPC with positron emission tomography for imaging the macrophage colony-stimulating factor 1 receptor	12
Semi-quantitative indices of 2-[18F]FDG PET/CT in assessing cardiovascular and non-cardiovascular manifestations of IgG4-related disease and treatment response	12
Reorganization of brain connectivity in post-COVID condition: a 18F-FDG PET study	12
MRI ensemble model of plaque and perivascular adipose tissue as PET-equivalent for identifying carotid atherosclerotic inflammation	12
Multi-organ glucose metabolism alterations in diabetes mellitus: a total-body 18F-FDG PET/CT study	12
The effects of novel macrocyclic chelates on the targeting properties of the 68Ga-labeled Gastrin releasing peptide receptor antagonist RM2	12
Correction: [18F]FE-PE2I PET is a feasible alternative to [123I]FP-CIT SPECT for dopamine transporter imaging in clinically uncertain parkinsonism	12
A dual-tracer approach using [11C]CH and [18F]FDG in HCC clinical decision making	12
A phase II study evaluating pharmacokinetics and dosimetry of 177Lu-PSMA-617 radioligand therapy in Chinese participants with progressive metastatic castration-resistant prostate cancer	12
Repeatability of tumour perfusion measurement with [15O]H2O PET in prostate cancer	11
cfDNA fragmentation patterns correlate with tumor burden measured via PSMA PET/CT volumetric parameters in patients with biochemical recurrence of prostate cancer	11
Effect of the identification group size and image resolution on the diagnostic performance of metabolic Alzheimer’s disease-related pattern	11
A tool for nuclear imaging of the SARS-CoV-2 entry receptor: molecular model and preclinical development of ACE2-selective radiopeptides	11
[18F]FDOPA PET/CT is superior to [68Ga]DOTATOC PET/CT in diagnostic imaging of pheochromocytoma	11
Prognostic value of 18F-FDG PET/CT-based radiomics combining dosiomics and dose volume histogram for head and neck cancer	11
Ultrasensitive detection of uveal melanoma using [18F]AlF-NOTA-PRGD2 PET imaging	10
Magnetic resonance spectroscopy for enhanced multiparametric MRI characterization of [18F]FET PET-negative gliomas	10
Quantitative terbium-161 SPECT/CT imaging: demonstrating the feasibility of image-based dosimetry and highlighting pitfalls	10
Development and validation of 68Ga-PSMA-11 PET/CT-based radiomics model to detect primary prostate cancer	10
Evaluation of therapeutic effect and prognostic value of 18F-FDG PET/CT in different treatment nodes of DLBCL patients	10
A study method using early dynamic acquisition of [18F]fluorodopa positron emission tomography for the differential diagnosis between progression and radionecrosis of brain metastases after radiothera	10
Fc-engineered monoclonal antibodies to reduce off-target liver uptake	10
Quantification in respiratory-gated PET acquisition: can data-driven methods replace device-based systems?—a comparative and retrospective study	10
Characterization of in vivo binding kinetics and non-displaceable binding of [18F]SynvesT-1 in the rat brain	9
Imaging renal mitochondrial dysfunction in chronic kidney disease: a repurposed role for [99mTc]Tc-MIBI SPECT/CT	9
The effect of androgen blockade on [68Ga]Ga-PSMA-11 and [18F]FDG PET uptake in patients with recurrent or metastatic salivary duct carcinoma: a prospective imaging study	9
Using advanced cell models for targeted radionuclide therapy evaluation: increased efficacy in 3D versus 2D	9
Deep learning-based radiolabelled compound-protein interaction prediction for NDUFS1-targeting radiopharmaceutical discovery	9

Distinguishing lymphoma from benign lymph node diseases in fever of unknown origin using PET/CT radiomics	9
Molecular imaging of fibroblast activation in multiple non-ischemic cardiomyopathies	9
68Ga-Pentixafor PET/CT for the assessment of therapeutic outcomes following superselective adrenal arterial embolization in patients with primary aldosteronism	9
Biphasic contrast-enhanced [18F]PSMA-1007 PET/CT imaging to improve the detection of local relapse of prostate cancer	9
Biodistribution and dosimetry of 177Lu-DOTA-IBA for therapy of bone metastases	9
Comparison between [68Ga]Ga-FAPI-46 and [18F]FDG PET/CT uptake in luminal-like vs. HER2-positive breast cancer	9
Spatial distribution of fractionally administered holmium microspheres in non-tumorous human liver tissue: how livers survive transarterial radioembolisation	8
Effects of furosemide and tracer selection on urinary activity and peri-bladder artefacts in PSMA PET/CT: a single-centre retrospective study	8
Dopamine transporter single-photon emission computed tomography-derived radiomics signature for detecting Parkinson’s disease	8
Accuracy and uncertainty analysis of reduced time point imaging effect on time-integrated activity for 177Lu-DOTATATE PRRT in patients and clinically realistic simulations	8
68Ga-NOTA-RM26 PET/CT in the evaluation of glioma: a pilot prospective study	8
Phantom and clinical evaluation of the effect of a new Bayesian penalized likelihood reconstruction algorithm (HYPER Iterative) on 68Ga-DOTA-NOC PET/CT image quality	8
Diagnostic and prognostic value of myocardial flow reserve quantification with single photon emission computed tomography – a systematic review and meta-analysis	8
Exploring the impact of PEGylation on pharmacokinetics: a size-dependent effect of polyethylene glycol on prostate-specific membrane antigen inhibitors	8
Impact of brain segmentation methods on regional metabolism quantification in 18F-FDG PET/MR analysis	8
Tumor sink effect on melanin-ligand [131I]ICF01012 in melanoma and its implications for targeted radionuclide therapy	8
3′-deoxy-3′-18F-fluorothymidine PET imaging of lymphoid tissues in patients with advanced non-small cell lung cancer undergoing anti-programmed cell death-1 therapy	8
[18F]F-FAPI-74 PET/CT for gonadal and extragonadal germ cell Tumors: a pilot study	8
Reduced hematopoietic-inflammatory response and worse outcomes in patients with recurrent myocardial infarction in comparison with primary myocardial infarction	8
Development of [89Zr]Zr-hCD103.Fab01A and [68Ga]Ga-hCD103.Fab01A for PET imaging to noninvasively assess cancer reactive T cell infiltration: Fab-based CD103 immunoPET	8
Light up heart-type fatty acid binding protein (FABP3) with a novel fluorine-18 labelled selective FABP3 ligand	8
Predictive value of 68[Ga]Ga-DOTA-TATE PET/CT volumetric parameters in assessing treatment response to long-acting somatostatin analogues in patients with well-differentiated neuroendocrine tumours	8
Chemotherapy alters radiosensitivity and GRPR expression of prostate and breast cancer cells	8
Total-body 18F-FDG PET/CT: more choices to promote clinical scanning efficiency	8
Characterisation of a novel [18F]FDG brain PET database and combination with a second database for optimising detection of focal abnormalities, using focal cortical dysplasia as an example	8
[18F]ROStrace detects oxidative stress in vivo and predicts progression of Alzheimer’s disease pathology in APP/PS1 mice	8
Accuracy of dynamic sentinel lymph node biopsy for inguinal lymph node staging in cN0 penile cancer	8
Preclinical in vivo dosimetry of healthy tissues in radiopharmaceutical therapy: implementation of a physiologically realistic mouse eye model in GATE	8
[18F]FDG PET-MR characterization of aortitis in the IL1rn−/− mouse model of giant-cell arteritis	8
Effect of radiation therapy on lymph node fluorescence in head and neck squamous cell carcinoma after intravenous injection of indocyanine green: a prospective evaluation	8
EJNMMI research: a vision for the next era of nuclear medicine	8
Imaging bone turnover assessment through volumetric density-adjusted standardized uptake value using quantitative bone SPECT/CT in osteoporosis	8
Preclinical evaluation of Affibody molecule for PET imaging of human pancreatic islets derived from stem cells	7
Myocardial glucose suppression may interfere with the detection of inflammatory cells with FDG-PET as suggested in a canine model of myocardial infarction	7
Evaluation of ultrasonographic and clinicopathological features of patients with abnormal [68Ga]Ga-DOTA-TATE uptake in the thyroid gland	7
Prospective comparison of [68Ga]Ga-FAPI-04 PET/CT and salivary gland scintigraphy for the diagnosis of primary Sjögren’s syndrome	7
Emerging need of dosimetry in radioligand therapy: a feasible method tested in a large cohort of patients affected by neuroendocrine neoplasms	7
[195mPt]Cisplatin for lung cancer imaging: a pilot study	7
Blood-based transcriptomic biomarkers for response to [177Lu]Lu-DOTA-TATE therapy in neuroendocrine tumors	7
Evaluation of the theranostic potential of [64Cu]CuCl2 in glioblastoma spheroids	7
Predicting survival, neurotoxicity and response in B-cell lymphoma patients treated with CAR-T therapy using an imaging features-based model	7
PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): methodological application in [18F]-FDOPA PET imaging	7
Biological efficacy of simulated radiolabeled Lipiodol® ultra-fluid and microspheres for various beta emitters: study based on VX2 tumors	6
Evaluation of [89Zr]Zr-girentuximab PET imaging of clear cell renal cell carcinoma in Chinese patients: a Phase 1 clinical study (ZIRDOSE-CP)	6
Metabolic phenotyping of hand automatisms in mesial temporal lobe epilepsy	6
External validation: a simulation study to compare cross-validation versus holdout or external testing to assess the performance of clinical prediction models using PET data from DLBCL patients	6
Myocardial perfusion and oxidative metabolism in healthy subjects: sex-specific insights from vasodilatory stress 11C-acetate PET	6
Effect of cerebral sinus venous thrombosis and its location on cerebral blood flow: a [15O]water PET study in acute stroke patients compared to healthy volunteers	6
AI may help to predict thyroid nodule malignancy based on radiomics features from [18F]FDG PET/CT	6
99mTc-Labeled FAPI SPECT and 18F-FDG PET imaging for visualization and evaluation of connective tissue disease-associated interstitial lung disease	6
Prostate-specific membrane antigen (PSMA) expression in primary and metastatic renal cell cancer (UroCCR-65 study)	6
Preclinical evaluation of glycan-targeting monoclonal antibodies for bimodal near-infrared fluorescence and photoacoustic imaging of gastrointestinal cancers	6
A feasibility study of [18F] FDG PET/CT radiomics in predicting high-risk cytogenetic abnormalities in multiple myeloma	6
Feasibility of a drop-in γ-probe for radioguided sentinel lymph detection in early-stage cervical cancer	6
A histogram of [18F]BBPA PET imaging differentiates non-neoplastic lesions from malignant brain tumors	6
Predictive value of 99mTc-MAA-based dosimetry in personalized 90Y-SIRT planning for liver malignancies	5
From imaging heterogeneity to clinical decision: a novel imaging biomarker based on bone marrow kinetics for advanced NSCLC patients in partial response	5
Kinetics of the amino acid uptake tracer O-(2-[18F]fluoroethyl)-L-tyrosine (FET) in human brain	5
Non-invasive visualization of pH changes within the tumor-micro-environment by positron emission tomography	5
The remodeling of metabolic brain pattern in patients with extracranial diffuse large B-cell lymphoma	5
18F-ASEM PET/MRI targeting alpha7-nicotinic acetylcholine receptor can reveal skeletal muscle denervation	5
Radiation protection considerations with [89Zr]Zr-girentuximab PET and surgery	5
Radiosensitization of NET cells by HSP90 inhibitor ganetespib is mediated through pleiotropic stress responses	5
Non-invasive quantification of 18F-florbetaben with total-body EXPLORER PET	5
Utility of quantitative standardized uptake value from pre-operative bone SPECT/CT for predicting post-surgical MRONJ healing response	5
Evaluation of [11C]UCB-A positron emission tomography in human brains	5
Brown adipose tissue machine learning nnU-Net V2 network using TriDFusion (3DF)	5
The intra- and interobserver variability of PSMA-expression scores in patients with primary prostate cancer	5
The effect of butylscopolamine on [18F]FDG uptake in the gastrointestinal tract is negligible and regionally variable	5
Heteroaryl derivatives of suvorexant as OX1R selective PET ligand candidates: Cu-mediated 18F-fluorination of boroxines, in vitro and initial in vivo evaluation	5
The assessment of left ventricular volume and function in gated small animal 18F-FDG PET/CT imaging: a comparative study of three commercially available software tools	5
Is CXCR4-targeted 68Ga-pentixafor PET/CT a reliable AVS-free modality for surgical decision-making and prognostic prediction in primary aldosteronism with bilateral adrenal lesions?	5
A peptide nucleic acid-based pretargeting approach using 161Tb for radionuclide therapy in a murine tumor model	5
Autoradiographic assessment of SynVesT-1 revealed changes in non-displaceable binding with demyelination and remyelination: implications for SV2A PET analysis	5
Clinical significance of diffuse [18F] AlF-NOTA-FAPI-04 uptake in the thyroid on PET/CT imaging	5
Glypican-3 targeted radiopharmaceuticals for hepatocellular carcinoma: a review of molecular platforms	5
PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer	5
Neuropathological correlations of 18F-florzolotau PET in a case with Pick’s disease	5
Scoring system and a simple nomogram for predicting radioiodine refractory differentiated thyroid cancer: a retrospective study	5
Neuromelanin-targeted 18F-P3BZA PET/MR imaging of the substantia nigra in rhesus macaques	4

Deep learning for Parkinson’s disease classification using multimodal and multi-sequences PET/MR images	4
Enhancing reader confidence through dual-time imaging and alternative reconstruction algorithms with [18F]PSMA-1007 PET/CT imaging in local relapsed castration-sensitive prostate cancer?	4
Early prognostic stratification of follicular lymphoma through ¹⁸F-FDG PET/CT tumor metabolic parameters and clinical characteristics	4
Evaluation of damage discrimination in dopaminergic neurons using dopamine transporter PET tracer [18F]FECNT-d4	4
[18F]Fluoride uptake in various bone types and soft tissues in rat	4
Simultaneous 18F-FDG PET/MR metabolic and structural changes in visual snow syndrome and diagnostic use	4
Comparative benefits of Ki and SUV images in lesion detection during PET/CT imaging	4
Subcutaneous injection of semaglutide causes increased muscle uptake of 18F-FDG and reduces the imaging quality of PET/CT: a case report	4
Data-driven identification and semi-automated quantification of molecular targets for tumour-imaging of colorectal liver metastases and primary colorectal tumours	4
Interreader agreement of intraprostatic prostate cancer detection, local extension and staging using [18F]PSMA-1007 PET and whole-mount radical prostatectomy specimens	4
Non-inferiority of automated deep learning-based [18F]FDG PET/CT tumour volume compared to manual GTV for prognostic modelling in head and neck cancer	4
FAPi-PET/CT as surrogate marker for subclinical myocardial fibrosis is a prognostic tool for patients undergoing left-sided heart valve surgery	4
Prospective comparison of [18F]AlF-NOTA-octreotide PET/MRI to [68Ga]Ga-DOTATATE PET/CT in neuroendocrine tumor patients	4
18F-FDG-PET/CT-based deep learning model for fully automated prediction of pathological grading for pancreatic ductal adenocarcinoma before surgery	4
Somatostatin receptor saturation after administration of high peptide amounts of [177Lu]Lu-HA-DOTATATE: when enough is enough	4
Head-to-head comparison of [177Lu]Lu-FAP-2286 and [161Tb]Tb-FAP-2286 efficacy in a PDAC mouse model	4
Preoperative assessment and prognostic prediction of gastric cancer patients with peritoneal metastasis using 18F-FDG PET/CT before conversion surgery	4
In-vivo inhibition of neutral endopeptidase 1 results in higher absorbed tumor doses of [177Lu]Lu-PP-F11N in humans: the lumed phase 0b study	4
CXCR4-targeted PET imaging in rheumatoid arthritis: a novel approach for monitoring disease activity and therapeutic response	4
Variability of the arterial input function in small-animal dynamic PET imaging	4
Model selection for dynamic PET compartmental modelling of 18F-FDG uptake using a long axial field-of-view PET scanner with delay and motion correction	4
Pulmonary uptake value (PUV): a new quantification method for lung PET/CT imaging	4
[18F]FDG PET/CT is a quantitative tool to probe vascular inflammation and immune system metabolic activation in atherosclerotic nonhuman primates	4
[68 Ga]Ga-FAPI-04 PET/CT may be a predictor for early treatment response in rheumatoid arthritis	4
Diagnostic accuracy of cerebral [18F]FDG PET in atypical parkinsonism	4
Diagnostic models for fever of unknown origin based on 18F-FDG PET/CT: a prospective study in China	4
PSMA-expressing, fluciclovine-negative vertebral hemangioma	4
Improving multi-pinhole CZT myocardial perfusion imaging specificity without changing sensibility by using adapted filter parameters	4
Test-retest properties of [11C]PXT012253 as a positron emission tomography (PET) radiotracer in healthy human brain: PET imaging of mGlu4	4
Evaluation of a simplified radiolabeling method for a PARP inhibitor in an animal model of breast cancer	4
Impact of non-regional lymph node metastases accurately revealed on 18F-PSMA-1007 PET/CT in the clinical management of metastatic hormone-sensitive prostate cancer	4
Peptide-based PET imaging agent of tumor TIGIT expression	4
Simultaneous perfusion and dopaminergic imaging using dual-isotope CZT SPECT/CT in dementia with Lewy bodies	4
Evaluation of a clinically efficient [18F]FDG PET/CT protocol: short dynamic and two-phase static imaging for differentiating malignant pulmonary lesions	4
A robust and versatile deep learning model for prediction of the arterial input function in dynamic small animal [18F] FDG PET imaging	4
Liver-FDG-uptake augments early PET/CT prognostic value for CD19-targeted CAR-T cell therapy in diffuse large B cell lymphoma	4
A preclinical study on the influence of linkers in [68Ga]Ga-NOTA-X-RM26 radiotracers for PET imaging of GRPR expression	4
Baseline 18F-FDG PET/CT radiomics for prognosis prediction in diffuse large B cell lymphoma	3
PSMA imaging as a non-invasive tool to monitor inducible gene expression in vivo	3
A heterodimeric radioligand labeled with gallium-68 targeting fibroblast activation protein	3
Glial reactivity in a mouse model of beta-amyloid deposition assessed by PET imaging of P2X7 receptor and TSPO using [11C]SMW139 and [18F]F-DPA	3
Lymphoscintigraphy findings in patients with chylothorax: influence of biochemical parameters	3
Radiofluorination of a highly potent ATM inhibitor as a potential PET imaging agent	3
FAPI PET/CT shows favorable potential for the evaluation of gallbladder cancer: a prospective study comparing [68Ga]Ga-FAPI-04 and [18F]FDG	3
Multinomial logistic regression algorithm for the classification of patients with parkinsonisms	3
The impact of patient hydration and forced diuresis on [18F]PSMA-1007 urinary bladder uptake in PET/CT imaging	3
[68Ga] labelled Exendin for radioguided surgery of intrapancreatic insulin producing lesions in patients with congenital hyperinsulinism	3
P2X 7-receptor binding in new-onset and secondary progressive MS – a [11C]SMW139 PET study	3
Relaxed fibronectin: a potential novel target for imaging endometriotic lesions	3
Prospective phase II trial of [68Ga]Ga-NOTA-AE105 uPAR-PET/MRI in patients with primary gliomas: Prognostic value and Implications for uPAR-targeted Radionuclide Therapy	3
A physiologically based pharmacokinetic model for [68Ga]Ga-(HA-)DOTATATE to predict whole-body distribution and tumor sink effects in GEP-NET patients	3
The complementary role of PSMA expression and [18F]FDG PET/CT in predicting thyroid cancer outcome: from black and white to shades of gray, in the era of precision oncology	3
The efficacy of short acquisition time using 18F-FDG total-body PET/CT for the identification of pediatric epileptic foci	3
Assessing vascular inflammation during continuous TSH suppression in differentiated thyroid cancer: a longitudinal [18F]FDG PET/CT analysis	3
Differentiation and correlation of regional uptake heterogeneity with cardiac dysfunction in biopsy-proven transthyretin amyloid cardiomyopathy using quantitative single-photon emission computed tomog	3
Effects of isoflurane anaesthesia depth and duration on renal function measured with [99mTc]Tc-mercaptoacetyltriglycine SPECT in mice	3
Relationships between uptake of [68Ga]Ga-DOTA-TATE and absorbed dose in [177Lu]Lu-DOTA-TATE therapy	3
In reply to Cheng et al. (DOI: 10.1186/s13550-023-00965-8)	3
Prognostic value of molecular and radiologic characteristics on dedicated breast [18F]FDG PET/MRI in breast cancer patients treated with neoadjuvant chemo(targeted) therapy: a retrospective cohort stu	3
Reliable localization of insulinomas with [68Ga]Ga-NODAGA-Lys40-Exendin-4: a preliminary evaluation and clinical illustration	3
Physiological provocation compared to acetazolamide in the assessment of cerebral hemodynamics: a case report	3
ImmunoPET provides a novel way to visualize the CD103+ tissue-resident memory T cell to predict the response of immune checkpoint inhibitors	3
Quantitative evaluation of thyroid bed accumulation in I-131 radiotherapy: a comparison of laryngeal edema and non-edematous cases	3
Visualizing GABA transporters in vivo: an overview of reported radioligands and future directions	3
Lesion conspicuity by size in [18F]FDG long-axial field-of-view PET/CT	3
Elimination of artifacts caused by residual radiopharmaceutical activity in injection site in myocardial perfusion imaging on Discovery NM 530c semiconductor gamma camera	3
Altered glucose metabolism in default mode network and prefrontal circuit in patients with Kallmann syndrome	3
Diagnostic and evaluative efficiency of 68Ga-FAPI-04 in skeletal muscle injury	3
Simultaneous partial volume correction and denoising of brain PET images, using transformers and transfer learning	3
Correction: Diagnostic and evaluative efficiency of 68Ga-FAPI-04 in skeletal muscle injury	3
Automatic volumetric estimates of the left and right atrium using dynamic PET	3
Heart ketone metabolism under acute ketone supplementation in ZDF rats, a type 2 diabetes heart failure model	3
Comparison of tracer kinetic models for 68Ga-PSMA-11 PET in intermediate-risk primary prostate cancer patients	3
In silico analysis of radiation-induced double-strand breaks by internal ex vivo irradiation of lymphocytes for 45 alpha- and beta/gamma-emitting radionuclides	3
Effects of novel androgen receptor signaling inhibitors on PSMA PET signal intensity in patients with castrate-resistant prostate cancer: a prospective exploratory serial imaging study	3
Preclinical evaluation and first-in-human study of [18F]AlF-FAP-NUR for PET imaging cancer-associated fibroblasts	3
Biomarkers of bone metabolism in [223Ra] RaCl2 therapy - association with extent of disease and prediction of overall survival	3
Non-invasive arterial input function estimation using an MRA atlas and machine learning	3
Effect of β3-adrenergic receptor agonists on [18F] fluorodeoxyglucose uptake in brown adipose tissues in positron emission tomography images of elderly patients	3
SPECT/CT in addition to subtraction parathyroid scintigraphy in hyperparathyroidism: diagnostic performance in a cohort of predominantly end-stage renal disease patients	2
Development and evaluation of the first-in-class nanobody based PET tracer targeting human inducible T-cell co-stimulator receptor	2
Correction: The association of DAT gene methylation with striatal DAT availability in healthy subjects	2
Establishing cutoff values for visual amyloid positivity in [18F]flutemetamol PET	2
Exploratory case series of circulating tumor DNA dynamics during tandem therapy in metastatic castration-resistant prostate cancer	2
Toward reproducible metabolic tumor volume quantification in endometrial cancer: optimizing [¹⁸F]FDG PET/CT tumor segmentation methods	2
Software compatibility analysis for quantitative measures of [18F]flutemetamol amyloid PET burden in mild cognitive impairment	2
Brain 18 F-FDG PET reveals cortico-subcortical hypermetabolic dysfunction in juvenile neuropsychiatric systemic lupus erythematosus	2
Evaluation of folate receptor-alpha and other surface markers as potential targets for radionuclide therapy of ovarian cancer	2
Radiomics predictive modeling from dual-time-point FDG PET Ki parametric maps: application to chemotherapy response in lymphoma	2
The impact of introducing deep learning based [18F]FDG PET denoising on EORTC and PERCIST therapeutic response assessments in digital PET/CT	2
Pilot study of humanized glypican-3-targeted zirconium-89 immuno-positron emission tomography for hepatocellular carcinoma	2
3D-printed dual holder system for simultaneous rat PET scanning: design and influence on quantification	2
Beyond discovery: are we understanding PET tracers as fast as we invent them? a critical review	2
Radioimmunotherapy study of 131I-labeled Atezolizumab in preclinical models of colorectal cancer	2
Unravelling physical and radiobiological effects of proton boron fusion reaction with anionic metallacarboranes ([o-COSAN]-) in breast cancer cells	2